Clinical Trial Update: Safety & Effectiveness of the PXL-Platinum 330 System for CXL Using Riboflavin Solution [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated the safety and effectiveness of the PXL-Platinum 330 System for corneal cross-linking using riboflavin solution; the study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Degeneration
• Corneal Ectasia
• Keratoconus
• Pellucid Marginal Corneal Degeneration

Drugs mentioned

• PXL Platinum 330 System
• Riboflavin solution (Riboflavin)

Snippet

Sponsor: Cornea Associates of Texas | Conditions: Keratoconus, Pellucid Marginal Corneal Degeneration | Phase 1 | Status: COMPLETED